Our multiple lines of experimental validation demonstrated that the proposed framework is robust in identifying high-quality, critical core p53 target lncRNAs and importantly, this approach can be applied to other transcriptional regulators in cancer or other diseases. The gene discussed is TP53; the disease is cancer.